Over half of new cancer drugs 'show no benefits' for survival or wellbeing. Of 48 cancer drugs approved between 2009-2013, 57% of uses showed no benefits and some benefits were ‘clinically meaningless’, says BMJ study.

See the source article by following the link below:
Over half of new cancer drugs 'show no benefits' for survival or wellbeing. Of 48 cancer drugs approved between 2009-2013, 57% of uses showed no benefits and some benefits were ‘clinically meaningless’, says BMJ study.